Literature DB >> 10980927

Is there any use for nontraditional or alternative therapies in patients with chronic liver disease?

N M Bass1.   

Abstract

There has been a substantial increase in the use of so-called complementary and alternative therapies by patients with liver disease. Although many such modalities are available, herbal therapies are the most popular, and of these remedies, silymarin extracted from the milk thistle is most widely subscribed to as a remedy for liver diseases. Available evidence points to a potential, but unproven, benefit for this as well as other therapies based on free radical scavenger or antioxidant principles in treating patients with liver disease. These therapies deserve further investigation through experimental studies and well-controlled clinical trials. Benefits to patients from these therapies, especially to patients with established cirrhosis, are most likely to be modest and insignificant. Conversely, the hepatotoxic potential of some alternative treatments is well recognized. As practitioners educating and treating patients with liver disease, we are obliged to be informed about popular alternative therapies, understanding of our patients' need to be partners in their care, and open-minded to the possibility that some benefit may come from some therapies currently regarded as alternative. We need to be effective and tolerant in learning about which alternative treatments our patients are taking, so that we can monitor their effects if any and counsel appropriately against those that may cause harm.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10980927     DOI: 10.1007/s11894-999-0087-2

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  47 in total

1.  Shark cartilage-induced hepatitis.

Authors:  B Ashar; E Vargo
Journal:  Ann Intern Med       Date:  1996-11-01       Impact factor: 25.391

2.  Protective effect of Legalon in workers exposed to organic solvents.

Authors:  S Szilárd; D Szentgyörgyi; I Demeter
Journal:  Acta Med Hung       Date:  1988

3.  Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C.

Authors:  R G Batey; A Bensoussan; Y Y Fan; S Bollipo; M A Hossain
Journal:  J Gastroenterol Hepatol       Date:  1998-03       Impact factor: 4.029

4.  Advising patients who seek alternative medical therapies.

Authors:  D M Eisenberg
Journal:  Ann Intern Med       Date:  1997-07-01       Impact factor: 25.391

5.  Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts.

Authors:  E C Fuchs; R Weyhenmeyer; O H Weiner
Journal:  Arzneimittelforschung       Date:  1997-12

Review 6.  Adverse effects of acupuncture: a study of the literature for the years 1981-1994.

Authors:  A J Norheim
Journal:  J Altern Complement Med       Date:  1996       Impact factor: 2.579

7.  A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis.

Authors:  G Buzzelli; S Moscarella; A Giusti; A Duchini; C Marena; M Lampertico
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1993-09

8.  Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage.

Authors:  A B Halim; O el-Ahmady; S Hassab-Allah; F Abdel-Galil; Y Hafez; A Darwish
Journal:  Ann Clin Biochem       Date:  1997-11       Impact factor: 2.057

Review 9.  Review article: S-adenosyl-L-methionine--a new therapeutic agent in liver disease?

Authors:  E Osman; J S Owen; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  1993-02       Impact factor: 8.171

10.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

View more
  2 in total

1.  Self microemulsifying formulation of Lagerstroemia speciosa against chemically induced hepatotoxicity.

Authors:  Gupta Amresh; Vipin Kumar Agarwal; Chandana Venkateswara Rao
Journal:  J Tradit Complement Med       Date:  2017-06-03

Review 2.  A current update on the rule of alternative and complementary medicine in the treatment of liver diseases.

Authors:  Yong-Song Guan; Qing He
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-10       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.